Concepedia

Author

Jayson Hardcastle

The Ohio State University Wexner Medical Center

Also Known As

J J Hardcastle, Jayson Hardcastle, Jayson J Hardcastle, X. Li

59

Publications

1.1K

Citations

11

H-Index

16

Concepts

All Affiliations

The Ohio State University Wexner Medical CenterThe Ohio State UniversityThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteNeurological SurgeryMayo Clinic in Arizona
JH

About

Jayson Hardcastle is an author at The Ohio State University Wexner Medical Center specializing in medicine, glioma, and cell death.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

248

2

Cell Biology

2

2

230

3

Immunology

2

2

220

4

Pharmacology

1

1

28

5

Immunotherapy

1

1

202

Jayson Hardcastle

×

10

Publications

1K

Citations

10

H-Index

YearCitations

NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors

Christopher Alvarez‐Breckenridge, Jianhua Yu, Richard L. Price,

Nature Medicine

2012

202

Effect of Tumor Microenvironment Modulation on the Efficacy of Oncolytic Virus Therapy

Kazuhiko Kurozumi, Jayson Hardcastle, Roopa Thakur,

JNCI Journal of the National Cancer Institute

2007

173

Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma

E. Antonio Chiocca, Laura K. Aguilar, Susan D. Bell,

Journal of Clinical Oncology

2011

157

Immunovirotherapy with measles virus strains in combination with anti–PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment

Jayson Hardcastle, Lisa Mills, Courtney S. Malo,

Neuro-Oncology

2016

134

Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1

Jayson Hardcastle, Kazuhiko Kurozumi, Nina Dmitrieva,

Molecular Therapy

2009

99

The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment

Walter H. Meisen, Eric S. Wohleb, Alena Cristina Jaime‐Ramirez,

Clinical Cancer Research

2015

94

Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61

Kazuhiko Kurozumi, Jayson Hardcastle, Roopa Thakur,

Molecular Therapy

2008

86

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Chelsea Bolyard, Walter H. Meisen, Yeshavanth Banasavadi‐Siddegowda,

Clinical Cancer Research

2016

36

SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma

Jeffrey Wojton, Walter H. Meisen, Naduparambil K. Jacob,

Oncotarget

2014

28

Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma

Evidio Domingo‐Musibay, Cory Allen, Cheyne Kurokawa,

Cancer Gene Therapy

2014

18

Page 1